Literature DB >> 21083341

Evaluating and defining sample preparation procedures for DBS LC-MS/MS assays.

Guowen Liu1, Laura Patrone, Heidi M Snapp, Alicja Batog, Jack Valentine, Greg Cosma, Adrienne Tymiak, Qin C Ji, Mark E Arnold.   

Abstract

BACKGROUND: A defined approach to develop and validate an LC-MS/MS assay using dried blood spot (DBS) samples is of great interest to many scientists who are adopting this technology. We have evaluated three distinct sample preparation procedures of DBS samples for LC-MS/MS assay development.
RESULTS: A new term 'elution efficiency' is introduced to evaluate the effectiveness of eluting compounds from the DBS cards into the liquid phase. Three different types of DBS cards were studied as part of the sample preparation procedures. A DBS LC-MS/MS method was developed, qualified and then applied to a toxicokinetics study.
CONCLUSION: Organic extraction and protein precipitation resulted in significant ion suppression and/or enhancement for FTA(®) Classic or FTA(®) Elute cards. Liquid-liquid extraction produced the least ion suppression/enhancement. Both protein precipitation and liquid-liquid extraction effectively eluted the probe compound from the DBS cards under the conditions tested. However, organic extraction by pure solvents resulted in low elution efficiency.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21083341     DOI: 10.4155/bio.10.106

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  2 in total

Review 1.  Dried blood spots in clinical lipidomics: optimization and recent findings.

Authors:  Helena Beatriz Ferreira; Inês M S Guerra; Tânia Melo; Hugo Rocha; Ana S P Moreira; Artur Paiva; M Rosário Domingues
Journal:  Anal Bioanal Chem       Date:  2022-07-15       Impact factor: 4.478

2.  Dried blood sample analysis by antibody array across the total testing process.

Authors:  Kelly Whittaker; Ying-Qing Mao; Yongping Lin; Huihua Zhang; Siwei Zhu; Hannah Peck; Ruo-Pan Huang
Journal:  Sci Rep       Date:  2021-10-15       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.